Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A morphologic variant of well differentiated liposarcoma occurring most often in the retroperitoneum and paratesticular area. It is characterized by the presence of bizarre hyperchromatic stromal cells and rare multivacuolated lipoblasts within a fibrous stroma.
Biomarker and diagnostic research for sclerosing liposarcoma has been reported in the published literature.
No clinical trials have been registered for sclerosing liposarcoma.
5 publications have been identified in PubMed for sclerosing liposarcoma. Research spans Review / Meta-Analysis (40%), Diagnostic / Biomarker (20%), and Case Report / Case Series (20%).
Fan P (2026). [PMID: 42019307](https://pubmed.ncbi.nlm.nih.gov/42019307/). *Am J Surg*. [Diagnostic / Biomarker]
Noorily AR (2025). [PMID: 38819449](https://pubmed.ncbi.nlm.nih.gov/38819449/). *Skeletal radiology*. [Review / Meta-Analysis]
Al-Maghrabi H (2025). [PMID: 40421095](https://pubmed.ncbi.nlm.nih.gov/40421095/). *Frontiers in oncology*. [Case Report / Case Series]
Zhang H (2025). [PMID: 40188451](https://pubmed.ncbi.nlm.nih.gov/40188451/). *Hellenic journal of nuclear medicine*. [Review / Meta-Analysis]
Li GZ (2025). [PMID: 40991882](https://pubmed.ncbi.nlm.nih.gov/40991882/). *JCO precision oncology*. [Epidemiology / Natural History]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 12:48 AM UTC